Navigation Links
Baxter's Board of Directors Declares Quarterly Dividend
Date:5/6/2008

Shareholders Re-elect Directors and Ratify Auditor at Annual Meeting

DEERFIELD, Ill., May 6 /PRNewswire-FirstCall/ -- The Board of Directors of Baxter International Inc. (NYSE: BAX) today announced a quarterly dividend and votes taken at the company's Annual Meeting of Shareholders held earlier today.

Baxter's Board of Directors declared a quarterly dividend of $0.2175 per share of Baxter common stock. This payment represents a continuation of the current rate. The quarterly dividend is payable on July 1, 2008 to shareholders of record as of June 10, 2008.

At its Annual Meeting of Shareholders held today in Chicago, Baxter shareholders re-elected five members of the company's board of directors -- Wayne T. Hockmeyer, Ph.D., Joseph B. Martin, M.D., Ph.D., Robert L. Parkinson, Jr., Thomas T. Stallkamp and Albert P.L. Stroucken -- for a term of three years. Shareholders also ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Baxter.

A webcast replay of Baxter's Annual Meeting of Shareholders can be accessed from a link on the company's website at http://www.baxter.com. Please visit Baxter's website for more information regarding this and future investor events and webcasts.

Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other conditions. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.


'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. KGI Elects Three New Members to Board of Trustees
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
5. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
6. BioLife Solutions Expands Scientific Advisory Board
7. NeurogesX Appoints New Director to the Board
8. Genstar Names Michael Hurt to Its Strategic Advisory Board
9. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
10. Bruce Pasternack Elected to Codexis Board
11. Interleukin Genetics Announces Management and Board Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  David Hardison, Ph.D., vice president of health ... been elected chairman of the board for the ... to establish common protocols around the use of ... electronic health records. Hardison will ... organizations across the research and health care arena ...
(Date:7/28/2014)... 2014 The global market for biotechnology ... according to a new study by Grand View Research, ... for effective vaccines and drugs in an attempt to ... is expected to drive market demand over the next ... productivity via the use of genetically engineered seeds is ...
(Date:7/26/2014)... 2014 Canada Endoscopy Visualization Systems ... on the Canada Endoscopy Visualization Systems market. The ... volume (in units) and average prices (in US ... Systems, Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy ... http://www.marketresearchreports.biz/analysis/213254 . , The report also provides company ...
(Date:7/25/2014)... , July 25, 2014 ... the "Global Metabolomics Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Metabolomics or Metabonomics is ... Metabolomics has become a new experimental technique that ... the environmental sciences. Metabolites are small molecules that ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2
... DxTech Enters Into Long-Term Strategic Alliance With Nicholas Piramal ... Point-of-Care Diagnostic ... DxTech LLC,("DxTech"), an innovation company focused on putting high-quality,diagnostic ... has entered,into a long-term strategic alliance with Nicholas Piramal ...
... of Sepracor Inc. (Nasdaq: SEPR ), ... Limited (ASX: HTW) today announced that,veteran healthcare executive ... as a non- executive director, effective immediately., ... chief executive,officer and chairman of Marlborough, MA-based Sepracor ...
... PARIS, April 30 ExonHit Therapeutics S.A.,(Alternext: ALEHT), ... its Supervisory Board., Following the annual shareholders, ... 25th, 2008, Mr. Edmund Olivier de Vezin,s appointment ... of the Board, expired,as he has reached the ...
Cached Biology Technology:DxTech and Nicholas Piramal in POC Diagnostics Alliance 2DxTech and Nicholas Piramal in POC Diagnostics Alliance 3DxTech and Nicholas Piramal in POC Diagnostics Alliance 4DxTech and Nicholas Piramal in POC Diagnostics Alliance 5HeartWare Appoints Timothy J. Barberich to Board of Directors 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 3
(Date:7/28/2014)... that the effects of a commonly used anesthetic drug ... The study, published in this week,s issue of the ... at the University of California, San Diego and Weill ... concerns, arising from multiple studies on humans over the ... increase their susceptibility to long-term cognitive and behavioral deficits, ...
(Date:7/28/2014)... Ore. The findings of a new study suggest two ... may not work as well in obese women, compared to ... pills are a one-size-fits-all method, researchers say, but as the ... well the pill works for obese women. Studies have consistently ... in the body, which may in turn affect how well ...
(Date:7/28/2014)... 28, 2014) Rice University researchers are using magnetic ... flexibility that can be used as microscale models for ... "bead-spring" polymers, introduced as theory in the 1950s, can ... and should be of interest to materials scientists who ... led by Rice chemical and biomolecular engineer Sibani Lisa ...
Breaking Biology News(10 mins):Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Strategies identified to improve oral contraceptive success with obese women 2Seeing is bead-lieving 2
... 2013  The following is being released by Wake Forest ... What:  A briefing for ... developments at Wake Forest Baptist Medical Center. Speakers are ... John D. McConnell , ...
... newly described species Alburnoides manyasensis , belongs the large ... as he carps, the minnows, and their relatives. This is ... of vertebrate animals, with the remarkable numbers of over 2,400 ... the largest part of biomass in most water types except ...
... to Research Careers) Program has announced the travel award ... 2013 meeting in Woods Hole, MA from March 9-14, ... of underrepresented minority students, postdoctorates and scientists into the ... the participation of young scientists at The Histochemical Society ...
Cached Biology News:Wake Forest Innovations Announces New Commercialization Developments 2
Lyophilized solid. Suitable for evaluating functional activity of human complement components and for other research requiring a high level of hemolytic activity. ...
... 220-240 V, uses floating pin printing technology ... and other biomolecules onto a variety of ... generate high-density arrays with greater than 80,000 ... 57,000 spots per membrane with a capacity ...
... systems are high-precision microarrayers capable of ... samples. VersArray ChipWriter Pro systems set ... and reproducibility to deliver unparalleled quality ... Their modular component design and flexible ...
... been developed for affinity capture of ... of ProteinChip chemical surfaces allow differential ... unique biochemical properties. Each chip has ... comparison, and the chips are color-coded ...
Biology Products: